Journal of Biological Chemistry · 2003 · 57 citations · 44 references
Life SciencesBiochemistryMolecular BiologyMolecular PhysiologyProtein-protein InteractionsSignal TransductionProtein DomainsProtein Interaction DomainsReceptor PhysiologyLigand Recognition MotifsReceptor-ligand RecognitionReceptors
The heptahelical receptors for corticotropin-releasing factor (CRF), CRFR1 and CRFR2, display different specificities for CRF family ligands: CRF and urocortin I bind to CRFR1 with high affinity, whereas urocortin II and III bind to this receptor with very low affinities. In contrast, all the urocortins bind with high affinities, and CRF binds with lower affinity to CRFR2. The first extracellular domain (ECD1) of CRFR1 is important for ligand recognition. Here, we characterize a bacterially expressed soluble protein, ECD1-CRFR2β, corresponding to the ECD1 of mouse CRFR2β. The K i values for binding to ECD1-CRFR2β are: astressin = 10.7 (5.4–21.1) nm, urocortin I = 6.4 (4.7–8.7) nm, urocortin II = 6.9 (5.8–8.3) nm, CRF = 97 (22–430) nm, urocortin III = sauvagine >200 nm. These affinities are similar to those for binding to a chimeric receptor in which the ECD1 of CRFR2β replaces the ECD of the type 1B activin receptor (ALK4). The ECD1-CRFR2β possesses a disulfide arrangement identical to that of the ECD1 of CRFR1, namely Cys45–Cys70, Cys60–Cys103, and Cys84–Cys118. As determined by circular dichroism, ECD1-CRFR2β undergoes conformational changes upon binding astressin. These data reinforce the importance of the ECD1 of CRF receptors for ligand recognition and raise the interesting possibility that different ligands having similar affinity for the full-length receptor may, nevertheless, have different affinities for microdomains of the receptor. The heptahelical receptors for corticotropin-releasing factor (CRF), CRFR1 and CRFR2, display different specificities for CRF family ligands: CRF and urocortin I bind to CRFR1 with high affinity, whereas urocortin II and III bind to this receptor with very low affinities. In contrast, all the urocortins bind with high affinities, and CRF binds with lower affinity to CRFR2. The first extracellular domain (ECD1) of CRFR1 is important for ligand recognition. Here, we characterize a bacterially expressed soluble protein, ECD1-CRFR2β, corresponding to the ECD1 of mouse CRFR2β. The K i values for binding to ECD1-CRFR2β are: astressin = 10.7 (5.4–21.1) nm, urocortin I = 6.4 (4.7–8.7) nm, urocortin II = 6.9 (5.8–8.3) nm, CRF = 97 (22–430) nm, urocortin III = sauvagine >200 nm. These affinities are similar to those for binding to a chimeric receptor in which the ECD1 of CRFR2β replaces the ECD of the type 1B activin receptor (ALK4). The ECD1-CRFR2β possesses a disulfide arrangement identical to that of the ECD1 of CRFR1, namely Cys45–Cys70, Cys60–Cys103, and Cys84–Cys118. As determined by circular dichroism, ECD1-CRFR2β undergoes conformational changes upon binding astressin. These data reinforce the importance of the ECD1 of CRF receptors for ligand recognition and raise the interesting possibility that different ligands having similar affinity for the full-length receptor may, nevertheless, have different affinities for microdomains of the receptor. corticotropin-releasing factor CRF receptor extracellular domain mouse 4-morpholineethanesulfonic acid high pressure liquid chromatography matrix-assisted laser desorption/ionization-time of flight-mass spectrometry Corticotropin-releasing factor (CRF)1 (1Vale W. Spiess J. Rivier C. Rivier J. Science. 1981; 213: 1394-1397Crossref PubMed Scopus (4000) Google Scholar) is the major neuroregulator of the hypothalamic-pituitary-adrenal axis and, among other roles, serves to integrate the endocrine, autonomic, and behavioral responses to stress. In addition to its central nervous system actions, CRF and its related ligands also affect the cardiovascular, reproductive, gastrointestinal, skin, and immune systems (2Perrin M.H. Vale W.W. Ann. N. Y. Acad. Sci. 1999; 885: 312-328Crossref PubMed Scopus (389) Google Scholar). The CRF ligand family includes (frog) sauvagine, (fish) urotensins, mammalian urocortin I (3Vaughan J. Donaldson C. Bittencourt J. Perrin M.H. Lewis K. Sutton S. Chan R. Turnbull A.V. Lovejoy D. Rivier C. Rivier J. Sawchenko P.E. Vale W. Nature. 1995; 378: 287-292Crossref PubMed Scopus (1396) Google Scholar, 4Donaldson C.J. Sutton S.W. Perrin M.H. Corrigan A.Z. Lewis K.A. Rivier J.E. Vaughan J.M. Vale W.W. Endocrinology. 1996; 137: 3896Crossref PubMed Scopus (197) Google Scholar), and the 38 amino acid peptides from the newly recognized genes urocortin II (5Reyes T.M. Lewis K. Perrin M.H. Kunitake K.S. Vaughan J. Arias C.A. Hogenesch J.B. Gulyas J. Rivier J. Vale W.W. Sawchenko P.E. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 2843-2848Crossref PubMed Scopus (812) Google Scholar) and urocortin III (6Lewis K. Li C. Perrin M.H. Blount A. Kunitake K. Donaldson C. Vaughan J. Reyes T.M. Gulyas J. Fischer W. Bilezikjian L. Rivier J. Sawchenko P.E. Vale W.W. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 7570-7575Crossref PubMed Scopus (831) Google Scholar), also known as stresscopin-related peptide and stresscopin (7Hsu S.Y. Hsueh A.J. Nat. Med. 2001; 7: 605-611Crossref PubMed Scopus (610) Google Scholar). The actions of CRF ligands are initiated by binding to their receptors, whose activation results in an increase of intracellular cAMP, hydrolysis of phosphoinositol, activation of mitogen-activated protein (MAP) kinases (8Grammatopoulos D.K. Randeva H.S. Levine M.A. Katsanou E.S. Hillhouse E.W. Mol. Endocrinol. 2000; 14: 2076-2091Crossref PubMed Scopus (124) Google Scholar, 9Brar B.K. Jonassen A.K. Stephanou A. Santilli G. Railson J. Knight R.A. Yellon D.M. Latchman D.S. J. Biol. Chem. 2000; 275: 8508-8514Abstract Full Text Full Text PDF PubMed Scopus (223) Google Scholar), and other signaling pathways (10Brar B.K. Perrin M.H. Vale W.W. H. Henry A.N. Encyclopedia of Hormones and Related Cell Regulators. Academic Press, Orlando, FL2002: 313-325Google Scholar). In mammals, two receptor types, CRFR1 and CRFR2, have been cloned (11Chen R. Lewis K.A. Perrin M.H. Vale W.W. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 8967-8971Crossref PubMed Scopus (899) Google Scholar, 12Perrin M. Donaldson C. Chen R. Blount A. Berggren T. Bilezikjian L. Sawchenko P. Vale W. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 2969-2973Crossref PubMed Scopus (492) Google Scholar, 13Vita N. Laurent P. Lefort S. Chalon P. Lelias J.M. Kaghad M. Le Fur G. Caput D. Ferrara P. FEBS Lett. 1993; 335: 1-5Crossref PubMed Scopus (298) Google Scholar, 14Chang C.-P. Pearse I.R.V. O'Connell S. Rosenfeld M.G. Neuron. 1993; 11: 1187-1195Abstract Full Text PDF PubMed Scopus (510) Google Scholar, 15Kishimoto T. Pearse II R.V. Lin C.R. Rosenfeld M.G. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 1108-1112Crossref PubMed Scopus (374) Google Scholar, 16Lovenberg T.W. Liaw C.W. Grigoriadis D.E. Clevenger W. Chalmers D.T. De Souza E.B. Oltersdorf T. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 836-840Crossref PubMed Scopus (831) Google Scholar, 17Stenzel P. Kesterson R. Yeung W. Cone R.D. Rittenberg M.B. Stenzel-Poore M.P. Mol. Endocrinol. 1995; 9: 637-645Crossref PubMed Google Scholar); orthologous receptors have also been identified in many other species including chicken (18Yu J. Xie L.Y. Abou-Samra A.-B. Endocrinology. 1996; 137: 192-197Crossref PubMed Scopus (68) Google Scholar), fish (19Arai M. Assil I.Q. Abou-Samra A.B. Endocrinology. 2001; 142: 446-454Crossref PubMed Scopus (135) Google Scholar), and Xenopus (20Dautzenberg F.M. Dietrich K. Palchaudhuri M.R. Spiess J. J. Neurochem. 1997; 69: 1640-1649Crossref PubMed Scopus (95) Google Scholar). A third receptor, CRFR3, with a high level of sequence identity to CRFR1, has been cloned in catfish (19Arai M. Assil I.Q. Abou-Samra A.B. Endocrinology. 2001; 142: 446-454Crossref PubMed Scopus (135) Google Scholar). CRF receptors have been characterized in the central nervous system and various peripheral sites including pituitary, gastrointestinal tract, epididymis, heart, gonad, adrenal, skin, and skeletal muscle. The CRF receptors are 7-transmembrane domain proteins with relatively large first extracellular domains (ECD1s). Both CRFR1 and CRFR2 exist as multiple splice variants and belong to the type B receptor family that includes receptors for growth hormone-releasing factor, secretin, calcitonin, vasoactive intestinal peptide, glucagon, glucagon-like peptide (GLP), and parathyroid hormone (2Perrin M.H. Vale W.W. Ann. N. Y. Acad. Sci. 1999; 885: 312-328Crossref PubMed Scopus (389) Google Scholar). The ligand specificities in binding to CRFR1 and CRFR2 are markedly different. Although both CRF and urocortin I bind with equally high affinities to CRFR1, the affinity of CRF for CRFR2 is at least 10 times lower than that of urocortin I. There is no high affinity interaction of either urocortin II or urocortin III with CRFR1, whereas their affinities for CRFR2 are in the subnanomolar range. The agonist, sauvagine, and the peptide antagonist, astressin, have equally high affinities for both types of receptors (5Reyes T.M. Lewis K. Perrin M.H. Kunitake K.S. Vaughan J. Arias C.A. Hogenesch J.B. Gulyas J. Rivier J. Vale W.W. Sawchenko P.E. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 2843-2848Crossref PubMed Scopus (812) Google Scholar, 6Lewis K. Li C. Perrin M.H. Blount A. Kunitake K. Donaldson C. Vaughan J. Reyes T.M. Gulyas J. Fischer W. Bilezikjian L. Rivier J. Sawchenko P.E. Vale W.W. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 7570-7575Crossref PubMed Scopus (831) Google Scholar, 21Perrin M.H. Sutton S.W. Cervini L.A. Rivier J.E. Vale W.W. J. Pharmacol. Exp. Ther. 1999; 288: 729-734PubMed Google Scholar). The majority of differences between the sequences of the two receptors are found in their ECD1s. Mutagenesis studies have identified regions of the receptors that are important for differential recognition of agonists and small molecule antagonists, as well as for governing the ligand selectivity of the two types of receptors (22Dautzenberg F.M. Kilpatrick G.J. Wille S. Hauger R.L. J. Neurochem. 1999; 73: 821-829Crossref PubMed Scopus (49) Google Scholar, 23Dautzenberg F.M. Wille S. Lohmann R. Spiess J. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 4941-4946Crossref PubMed Scopus (56) Google Scholar, 24Liaw C.W. Grigoriadis D.E. Lorang M.T. DeSouza E.B. Maki R.A. Mol. Endocrinology. 1997; 11: 2048-2053Crossref PubMed Scopus (113) Google Scholar, 25Liaw C.W. Grigoriadis D.E. Lovenberg T.W. De Souza E.B. Maki R.A. Mol. Endocrinol. 1997; 11: 980-985Crossref PubMed Scopus (76) Google Scholar, 26Perrin M.H. Fischer W.H. Kunitake K.S. Craig A.G. Koerber S.C. Cervini L.A. Rivier J.E. Groppe J.C. Greenwald J. Moller Nielsen S. Vale W.W. J. Biol. Chem. 2001; 276: 31528-31534Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar, S. S. Palchaudhuri M.R. Spiess J. F.M. J. Neurochem. 1999; PubMed Scopus Google Scholar). data from chimeric receptors in which the ECD1 of CRFR1 is to domains of other receptors the importance of the ECD1 in M.H. Sutton S. Berggren T.W. Vale W.W. Endocrinology. 1998; PubMed Scopus (95) Google Scholar, I.Q. M. M. Abou-Samra A.B. 2001; PubMed Scopus Google Scholar). a soluble protein corresponding to the ECD1 of CRFR1 expressed either in or mammalian binds astressin and urocortin with high affinity M.H. Sutton S. Berggren T.W. Vale W.W. Endocrinology. 1998; PubMed Scopus (95) Google Scholar, S. L. T. K. Spiess J. Sci. 2001; PubMed Scopus Google Scholar). amino have been identified in the ECD1 of the type CRF receptor that to the differences in ligand recognition of the Xenopus and receptors F.M. J. Hauger R.L. Mol. Pharmacol. PubMed Scopus Google Scholar). of the of the ECD1 of CRFR2 in the binding of the CRF ligands from an of their binding to the ECD1 from the of the receptor. In this we and of a soluble protein corresponding to the ECD1 of mouse that the affinities of the CRF ligands for the soluble protein are similar to those for a chimeric receptor in which the ECD1 of CRFR2β is in the by a domain of the type activin receptor P. H. P. P. J. H. K. 1993; Google Scholar). we the disulfide arrangement of the ECD1 and that is identical to that of the ECD1 for we that ligand binding a conformational in the A amino of with and and the of the by The to to an A = and with for either at or at The in 10 of and at for The soluble ECD1-CRFR2β, as a protein in the to and by affinity chromatography with ECD1-CRFR2β amino at the in from the The sequence of ECD1-CRFR2β is is the amino and are of the and The chimeric receptors in which amino of or amino of CRFR1 the first amino of the type 1B activin receptor, or by of as M.H. Sutton S. Berggren T.W. Vale W.W. Endocrinology. 1998; PubMed Scopus (95) Google Scholar). CRF as J. Rivier C. Perrin M. Koerber S.C. Sutton S. Corrigan A. Craig A.G. Vale W. Rivier J. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: PubMed Scopus Google Scholar). for the other peptides have been J. Rivier C. Perrin M. Koerber S.C. Sutton S. Corrigan A. Craig A.G. Vale W. Rivier J. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: PubMed Scopus Google Scholar). of has been M.H. Sutton S.W. Cervini L.A. Rivier J.E. Vale W.W. J. Pharmacol. Exp. Ther. 1999; 288: 729-734PubMed Google of is similar to that of and binding to as M.H. Sutton S. Berggren T.W. Vale W.W. Endocrinology. 1998; PubMed Scopus (95) Google Scholar). The data for the chimeric receptors are from of the the data for the receptor are from of of of A with of peptides of and of A or of in a of soluble protein of of B with of peptides of and of in a of for at in with The and the with The in the by i the data by a in at least The ECD1-CRFR2β to by in at for A large all by sequence and sequences with and The to by and The by and by sequence identified that an at = sequence two major sequences corresponding to that of and The for this is The of an = sequence two major sequences corresponding to and The for the is These by with and by In both the in to corresponding to the with an as low ECD1-CRFR2β or astressin, nm, of of of nm, of high ECD1-CRFR2β, astressin, all other as in to the by the of G. R. R. PubMed Scopus Google Scholar) and the the The ECD1-CRFR2β for the and by In we to in of a soluble of the ECD1 from CRFR1 M.H. Fischer W.H. Kunitake K.S. Craig A.G. Koerber S.C. Cervini L.A. Rivier J.E. Groppe J.C. Greenwald J. Moller Nielsen S. Vale W.W. J. Biol. Chem. 2001; 276: 31528-31534Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar). we found that the amino corresponding to the peptide of the ECD1 in the CRFR1, expressed in mammalian that amino of its peptide and are in its a amino of to a of in which is of disulfide as a of in and The ECD1 as a soluble the soluble protein, ECD1-CRFR2β, The protein amino and amino of the amino the and other amino from the and the by of the protein and its that the of the protein is the of the is and the of the ECD1-CRFR2β is the of = = of the of ECD1-CRFR2β is an of its affinity for the CRF family In we the by astressin, urocortins or sauvagine of to we also the by the ligands of to the expressed in The affinities of the agonists urocortin and urocortin II as well as of astressin for the soluble ECD1 are similar to their affinities for the receptor, whereas the affinities of urocortin III and sauvagine for ECD1-CRFR2β are lower than their affinities for the the of the ECD1 of in the of a we a chimeric receptor, in which the ECD1 of the ECD of the type 1B activin receptor a receptor P. H. P. P. J. H. K. 1993; Google Scholar). The to this by CRF family ligands are in the of urocortin urocortin and astressin are similar to their for the full-length receptor, whereas both urocortin III and sauvagine have very low the affinities of the CRF family ligands for this chimeric receptor are the as those for with the of of astressin by of sauvagine is the of binding of to either the ECD1-CRFR2β or the These data are in the first of binding to a chimeric receptor in which the ECD1 of CRFR1 replaces the ECD of is also The low affinity binding of urocortin II and urocortin III for the the ECD1 of CRFR1 is in with the low affinity binding of ligands for the full-length type CRF binding K i for CRF family ligands binding to various of CRF values are from at least determined by of values are from at least determined by of values are from at least determined by of values are from at least determined by of values are from at least determined by of The values are from at least determined by of The values are from at least determined by of in a for we in I the the affinities from of sauvagine to that the affinities of of the are the as the determined by of astressin, the K i of sauvagine is times and that of urocortin III is times than i values determined from of characterize the soluble protein at a we determined the The disulfide arrangement of the ECD1-CRFR2β determined by a similar to the for the protein M.H. Fischer W.H. Kunitake K.S. Craig A.G. Koerber S.C. Cervini L.A. Rivier J.E. Groppe J.C. Greenwald J. Moller Nielsen S. Vale W.W. J. Biol. Chem. 2001; 276: 31528-31534Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar). The protein by that between The by and to sequence a in corresponding to the of the sequence two corresponding to the with to the of the sequence The of the of two of the disulfide The found to of the peptides and from a between and The other of peptides and and the between and The between by sequence of the The of the at and in a species by a between and A of the disulfide is in The of is identical to that found in the ECD1 of CRFR1 M.H. Fischer W.H. Kunitake K.S. Craig A.G. Koerber S.C. Cervini L.A. Rivier J.E. Groppe J.C. Greenwald J. Moller Nielsen S. Vale W.W. J. Biol. Chem. 2001; 276: 31528-31534Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar) and also in the related parathyroid hormone receptor U. H. K. M. D. A. W. R. 2000; PubMed Scopus Google Scholar). The of ECD1-CRFR2β, ligand by circular in the of ECD1-CRFR2β in the and of astressin. The of ECD1-CRFR2β in low or are and are by the with from the and by the of G. R. R. PubMed Scopus Google Scholar) in of and for the and the of ligand ECD1-CRFR2β with astressin, and the of the with the of the of the The the of with a and a increase in the of the in the nm. of the of the conformational of and for the and the and data that with astressin, ECD1-CRFR2β with a increase in and to a the in of protein and and the of ECD1-CRFR2β to astressin is of the in is by a small of the from changes in the astressin the major changes changes in the of The CRF system of the related ligands (frog) sauvagine, (fish) urocortin the mammalian urocortin II and urocortin III to stresscopin-related peptide and and the receptors, CRFR1 and CRFR2, from two receptor in at least two as a of The CRF receptors belong to the type B receptor family whose are characterized by large with the and of the type CRF receptor, we to the ligand binding of a soluble of the ECD1 for of astressin, we that the soluble protein, ECD1-CRFR2β, binds astressin, urocortin and urocortin II with high affinities binds CRF with affinity and binds urocortin III and sauvagine with low affinities the of is no binding of sauvagine to ECD1-CRFR2β, and of astressin by urocortin III or sauvagine is at high of binding of sauvagine also for the ECD1 of CRFR1 M.H. Fischer W.H. Kunitake K.S. Craig A.G. Koerber S.C. Cervini L.A. Rivier J.E. Groppe J.C. Greenwald J. Moller Nielsen S. Vale W.W. J. Biol. Chem. 2001; 276: 31528-31534Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar). In the affinities for ECD1-CRFR2β are: astressin urocortin I urocortin urocortin III These data are by data a chimeric receptor, in which the ECD1 of is to the by of the domain of a type activin receptor. The of the ligands in binding to the are similar to those for binding to the The that sauvagine astressin to the soluble ECD1 of either the type or type receptor that other regions of the receptor are for binding of These data are with those that the affinity of sauvagine and that the affinity of CRF in binding to a chimeric receptor in which the ECD1 of CRFR1 the corresponding ECD1 of the parathyroid hormone receptor I.Q. M. M. Abou-Samra A.B. 2001; PubMed Scopus Google Scholar). In that sauvagine to the extracellular of CRFR1 I. Abou-Samra A.B. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The large in affinity of urocortin III for the ECD1 of CRFR2β also for this other regions of the receptor are for high affinity for is that sauvagine and urocortin III of the receptor to a whereas urocortin I and urocortin II are to bind with high affinity to receptors in of These data are with the of of binding of urocortin I M.H. Sutton S.W. Cervini L.A. Rivier J.E. Vale W.W. J. Pharmacol. Exp. Ther. 1999; 288: 729-734PubMed Google Scholar, A. I. A.K. 1999; PubMed Scopus Google Scholar) and with the that urocortin I F.M. G. J. Fischer C. M.B. G. J. Pharmacol. Exp. Ther. 2001; Google Scholar). The data in I that the affinities of urocortin III and of sauvagine for the of the that is in the both astressin is the K i values are than those by of The affinities of urocortin I and of urocortin II to the of the These are similar to those in F.M. G. J. Fischer C. M.B. G. J. Pharmacol. Exp. Ther. 2001; Google Scholar) in which a similar in the affinity of sauvagine in the affinity of urocortin I in of astressin, as with their affinities determined from of The that the of disulfide in the ECD1 of CRFR2β is the as that determined for the ECD1 of CRFR1 M.H. Fischer W.H. Kunitake K.S. Craig A.G. Koerber S.C. Cervini L.A. Rivier J.E. Groppe J.C. Greenwald J. Moller Nielsen S. Vale W.W. J. Biol. Chem. 2001; 276: 31528-31534Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar), which in is the as that of the ECD1 of the parathyroid hormone receptor U. H. K. M. D. A. W. R. 2000; PubMed Scopus Google Scholar). The of high affinity ligand binding and of a disulfide with no that the bacterially expressed protein a to that of the receptor. to the that the of in the ECD1 of this of receptors are in a that characterize the family of A similar of disulfide arrangement is found in a of small peptides including and whose have been S. L. 2001; PubMed Scopus Google Scholar). the in the the is identical in all is to that the ECD1 of the CRF receptors a similar is interesting to that the ECD of receptors for the and related ligands the that been with a family of small peptides J. Fischer W.H. Vale W.W. S. Nat. Biol. 1999; PubMed Scopus (135) Google Scholar). The that the of ECD1-CRFR2β at in both low and are by that this is by the interaction with astressin that ECD1-CRFR2β as a of large in at has been in the interaction of astressin with the soluble ECD1 of CRFR1 M.H. Fischer W.H. Kunitake K.S. Craig A.G. Koerber S.C. Cervini L.A. Rivier J.E. Groppe J.C. Greenwald J. Moller Nielsen S. Vale W.W. J. Biol. Chem. 2001; 276: 31528-31534Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar). of soluble those for the receptors for hormone A. R. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar), C. J. D. L. R. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar), K. J. P. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar), parathyroid hormone U. H. K. M. D. A. W. R. 2000; PubMed Scopus Google Scholar), A. R. FEBS Lett. 1996; PubMed Scopus (49) Google Scholar), and T. N. M. Y. A. S. H. J. Biol. Chem. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar). A conformational as determined from found for the soluble ECD1 of the hormone receptor binding of hormone A. R. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar). from an of the of the soluble hormone that characterized by than C. J. D. L. R. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar), and similar data from the ECD1 of the parathyroid hormone receptor and U. H. K. M. D. A. W. R. 2000; PubMed Scopus Google Scholar). data from have been for ECD1 of the receptor, which has been characterized to N. Y. Y. T. M. T. S. H. K. Nature. 2000; PubMed Scopus Google Scholar). In we have found that a soluble protein, expressed in corresponding to the first extracellular domain of the binds with affinity the CRF family urocortin I and urocortin as well as a peptide antagonist, astressin. The agonist, binds with high affinity, whereas the agonists urocortin III and sauvagine display low affinities for the soluble The disulfide of the ECD1 of CRFR2β is the as that of the ECD1 of CRFR1 and a for the receptor is a conformational in the ECD1 binding of astressin. is to that the ligands of the CRF family have with the receptors in a that the to high affinity ligand binding of the to that of other receptor is for the ECD1 is a major of high affinity interaction for urocortin and urocortin whereas with other domains of the receptor to important for high affinity binding of urocortin III and A the activation of CRF receptors by of the signaling of a chimeric receptor in which the ECD1 of CRFR1 by the first amino of data that the ECD1 of the CRF receptors with the of ligands as urocortin and urocortin which are in the to the of the ligand to the of the receptor for to with data from soluble proteins as the ECD1 of the CRF C. Perrin for and A. R. W. M. K. L. and J. Vaughan for
44
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
N. Kunishima, Yoshimi Shimada, Yuji Tsuji et al. · Nature · 2000 · 1.2K citations